Central nervous system cytokine gene expression: modulation by lead.

Area of Science:

• Neuroscience
• Toxicology
• Developmental Biology

Background:

• Lead (Pb) is a heavy metal toxicant with greater harm to the developing central nervous system (CNS) in children.
• Growth factors and cytokines are crucial for CNS development, making their response to Pb exposure a key area of study.

Purpose of the Study:

• To investigate the impact of developmental lead exposure on cytokine expression within the CNS.
• To understand the molecular mechanisms underlying lead's neurotoxicity, focusing on astrocyte activation and neural connections.

Main Methods:

• Lead acetate exposure in BALB/c mouse pups from gestation day 8 (gd8) to post-natal day 21 (pnd21).
• Analysis of cytokine expression using microarray, real-time RT-PCR, Luminex, and ELISA.
• Quantification of glial-fibrillary acidic protein (GFAP) as an astrocyte marker.

Main Results:

• Lead exposure significantly altered the transcript levels of interleukin-6 (IL-6) and transforming growth factor-β1 (TGF-β1).
• Increased expression of GFAP, an astrocyte marker, was observed following lead exposure.
• Lead modulated protein expression of IL-6, TGF-β1, and IL-18 in specific brain regions.

Conclusions:

• Developmental lead exposure alters CNS cytokine profiles and promotes astrocyte activation (GFAP expression).
• These changes may underlie lead's detrimental effects on learning and memory by interfering with neural connections.
• Further investigation into regional cytokine expression is necessary to mechanistically link lead-induced neuroinflammation to cognitive impairments.